Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × gadoterate meglumine × Clear all

Phase

Phase 4 3 Phase NA 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Cisplatin 617 Carboplatin 511 Paclitaxel 495 Radiotherapy 454 Cyclophosphamide 454 Docetaxel 414 Fluorouracil 384 Gemcitabine 368 Doxorubicin 343 Capecitabine 319 Dexamethasone 284 Oxaliplatin 249 Vincristine 236 pembrolizumab 235 Leucovorin 235 Etoposide 231 Bevacizumab 227 Rituximab 209 Prednisone 201 Pemetrexed 181 Cytarabine 180 Drug Therapy 173 Methotrexate 152 Trastuzumab 149 Irinotecan 141 Lenalidomide 123 Filgrastim 119 Nivolumab 113 Chemotherapy, Adjuvant 111 Tamoxifen 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06057168 2026-01-29

GDX-44-016

Guerbet

Phase 3 Completed

138 enrolled 7 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡